TrademarkDir
REVENIR
LIVE

Serial Number

79370662

Owner

Congruence Therapeutics Inc.

Attorney

Kelsey C. Coplan

Filing Date

Mar 15, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

REVENIR Trademark

Serial Number: 79370662 • Registration: 7616651

REVENIR is a trademark filed by Congruence Therapeutics Inc. on March 15, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Congruence Therapeutics Inc. (3 trademarks)

7171 Rue Frederick-Banting

Entity Type: 99

Trademark Details

Filing Date

March 15, 2023

Registration Date

December 24, 2024

Published for Opposition

November 5, 2024

Goods & Services

Platform as a service (PaaS) featuring computer software platforms for computational drug discovery

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 5, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 5, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2026 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 11, 2025 FICS
FINAL DISPOSITION PROCESSED
Jun 10, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 24, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 9, 2024 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 23, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 23, 2024 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2024 NREP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 30, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 31, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 8, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 8, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 23, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 22, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 30, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 25, 2023 REPR

Related Trademarks

More from this Owner

CONGRUENCE

CONGRUENCE

CONGRUENCE

CONGRUENCE

CONGRUENCE

CONGRUENCE

CONGRUENCE THERAPEUTICS

CONGRUENCE THERAPEUTICS

CONGRUENCE THERAPEUTICS

CONGRUENCE THERAPEUTICS